NPD [China Nepstar Chain Drugstore] 6-K: (Original Filing)

[China Nepstar Chain Drugstore Reports First Quarter 2010 Financial Results Same Store Sales Growth 6.9% — — Shenzhen, China, May 18, 2010 Financial Highlights For the quarter ended March 31, 2010: § Revenue was RMB567 million (US$83 million), reflecting a 12.1% increase compared to revenue of RMB506 million in the first quarter of 2009 § Same store sales increased by]

NPD [China Nepstar Chain Drugstore] 6-K: China Nepstar Chain Drugstore Reports First Quarter 2010

[China Nepstar Chain Drugstore Reports First Quarter 2010 Financial Results Same Store Sales Growth 6.9% — — Shenzhen, China, May 18, 2010 Financial Highlights For the quarter ended March 31, 2010: § Revenue was RMB567 million (US$83 million), reflecting a 12.1% increase compared to revenue of RMB506 million in the first quarter of 2009 § Same store sales increased by]

NPD [China Nepstar Chain Drugstore] 20-F: (Original Filing)

[] [SUPPLEMENTAL AGREEMENT TO THE EQUITY PLEDGE AGREEMENT This Supplemental Agreement to the Equity Pledge Agreement (this “Supplemental Agreement”) is entered into by and between the following parties on [August 18], 2009 in [Shenzhen]: PLEDGEE: Party A: Shenzhen Nepstar Pharmaceutical Coompany Ltd. Registered address: Neptunus Building A-15B, Nanshan District, Shenzhen PLEDGORS: Party B: Feng Tu ID No.: 320828196810190013 Party C: Liping] [SUBSIDIARIES OF THE COMPANY Wholly—owned subsidiaries, each of which is duly incorporated in the PRC: • Shenzhen Nepstar Pharmaceutical Electronic Technologies Ltd. • Shenzhen Nepstar Commerce Development Ltd. • Shenzhen Jinfu Logistics Service Co., Ltd. • Shenzhen Wisconsin Trading Development Co., Ltd. • Shenzhen Nepstar Pharmaceutical Co., Ltd. • Shenzhen Nepstar Industrial Co., Ltd. • Shenzhen Nepstar E-Commerce Co., Ltd.] [I, Ian F. Wade, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [I, William Weili Dai, certify that: 1. I have reviewed this annual report on Form 20-F of China Nepstar Chain Drugstore Ltd.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such] [Certification by the Chief Executive Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. By] [Certification by the Chief Financial Officer (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.] [Consent of Independent Registered Public Accounting Firm The Board of Directors We consent to the incorporation by reference in the registration statement (No. 333-147702) on Form S-8 of China Nepstar Chain Drugstore Ltd. of our reports dated April 30, 2010, with respect to the consolidated balance sheets of China Nepstar Chain Drugstore Ltd. as of December 31, 2008 and 2009,]

NPD [China Nepstar Chain Drugstore] SC 13G/A: * The remainder of this cover page shall

[* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed]

By | 2016-03-07T06:22:03+00:00 February 12th, 2010|Categories: Chinese Stocks, NPD, Webplus ver|Tags: , , , , , |0 Comments

NPD [China Nepstar Chain Drugstore] SC 13G/A: (Original Filing)

[* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed]

Skip to toolbar